US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

202.64

-2.8500-1.39%

Pre-market: 202.14-0.5000-0.25%04:01 EDT

Volume:1.89M

Turnover:384.71M

Market Cap:10.26B

PE:32.10

High:204.66

Open:203.59

Low:201.92

Close:205.49

52wk High:217.12

52wk Low:138.79

Shares:50.65M

Float Shares:50.65M

Volume Ratio:1.38

T/O Rate:3.74%

Dividend:0.41

Dividend Rate:0.20%

EPS(TTM):6.31

EPS(LYR):-1.4940

ROE:24.54%

ROA:0.10%

PB:1.26

PE(LYR):-135.64

Loading ...

Overview Company News Filings

UK Regulator Suspends Avacopan Vifor for New Patients

MT Newswires Live

Novartis halts autoimmune CAR-T trials following three deaths, Reuters says

Vertex Pharmaceuticals added to US Conviction List at Goldman Sachs

UK's Mhra : Informed Marketing Authorisation Holder of Decision to Suspend Use, Supply, Sale of Avacopan Vifor for New Patients from 1 September

THOMSON REUTERS

Latigo Biotherapeutics initiated with a Buy at Goldman Sachs

Why Is Amgen (AMGN) In Focus After New Repatha Survival Data?

Simply Wall St.

Vertex Advances Share Buyback, Acquires 445,500 Shares by August

Vertex (VRTX) Stock Looks Reasonable As Growth Must Justify Its Run

Simply Wall St.

Actinogen Plans Major Share Placement to Bolster Funding Capacity

Is Pasatru’s Rare Disease Approval With Home Infusion Potential Altering The Investment Case For Regeneron Pharmaceuticals (REGN)?

Simply Wall St.

Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others

Circio boosts circVec gene therapy data and secures funding runway to 2030

iShares Biotechnology ETF Announces Q3 2026 Dividend of R$ 0.02 Per Unit

Sector Update: Healthcare Stocks Decline Monday Afternoon

MT Newswires Live

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as US, Iran Exchange Attacks

MT Newswires Live

Political and General News Events from August 31

Sector Update: Healthcare

MT Newswires Live

Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients

MT Newswires Live

Amgen Repatha reduces risk of death in high-risk adults for first heart attack

Chimeric Therapeutics posts deeper loss as IP impairments push it into net liabilities

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/IBB/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"iShares Biotechnology ETF","latestPrice":202.64,"timestamp":1789070400000,"preClose":205.49,"halted":0,"volume":1894455,"hourTrading":{"tag":"盘前","latestPrice":202.14,"preClose":202.64,"latestTime":"04:01 EDT","volume":5,"amount":1011.27,"timestamp":1789113662647,"change":-0.5,"changeRate":-0.002467,"amplitude":0},"delay":0,"changeRate":-0.013869288043213891,"floatShares":50650000,"shares":50650000,"eps":6.311863,"marketStatus":"Pre-Mkt","change":-2.85,"latestTime":"09-11 04:17:31 EDT","open":203.59,"high":204.66,"low":201.924,"amount":384708037.7448,"amplitude":0.013315,"askPrice":223.15,"askSize":100,"bidPrice":182.9,"bidSize":100,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789133400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":202.64,"sharesOutstanding":49450000,"nav":205.458405,"aum":10437286974,"dividendRate":0.002,"bidAskSpread":0.000306,"preHourTrading":{"tag":"盘前","latestPrice":202.14,"preClose":202.64,"latestTime":"04:01 EDT","volume":5,"amount":1011.27,"timestamp":1789113662647,"change":-0.5,"changeRate":-0.002467,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":202.3531,"preClose":202.64,"latestTime":"19:44 EDT","volume":31689,"amount":6417724.8659,"timestamp":1789083850615,"change":-0.2869,"changeRate":-0.001416,"amplitude":0.003158},"volumeRatio":1.377035545883969,"optionData":{"bulkOrders":[{"symbol":"IBB","call":false,"expireDate":1789704000000,"strike":"200.0","timestamp":1789065070005,"price":1.6,"volume":1700,"amount":272000,"type":"+"}]},"impliedVol":0.2379,"impliedVolPercentile":0.56},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50650000,"roa":"0.10%","roe":"24.54%","lyrEps":-1.493977,"volumeRatio":1.377035545883969,"shares":50650000,"dividePrice":0.4053,"high":204.66,"amplitude":0.013315,"preClose":205.49,"low":201.924,"week52Low":138.785,"pbRate":"1.26","psRate":"246.94","week52High":217.12,"institutionHeld":0,"latestPrice":202.64,"eps":6.311863,"divideRate":0.002,"volume":1894455,"delay":0,"ttmEps":6.311863,"open":203.59,"prevYearClose":168.77,"prevWeekClose":211.92,"prevMonthClose":209.05,"prevQuarterClose":190.19,"fiveDayClose":213.8,"twentyDayClose":200.72,"sixtyDayClose":172.17},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"},{"date":"2025-03-18","symbol":"IBB","amount":0.121169,"announcedDate":"2025-03-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-18","defaultRemindTime":1742304600000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-21","payableDate":"2025-03-18","currency":"USD","dateTimestamp":1742270400000,"payDate":"2025-03-21"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.0858219,"currency":"USD"},{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664385377","title":"UK Regulator Suspends Avacopan Vifor for New Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2664385377","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664385377?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:03","pubTimestamp":1788260615,"startTime":"0","endTime":"0","summary":"The UK's health regulator has suspended the use, supply and sale of Avacopan Vifor, previously known as Tavneos, for new patients from Sept. 1, the watchdog said Tuesday.The Medicines and Healthcare products Regulatory Agency said available evidence no longer supports a positive benefit-risk balance for the medicine, which is used to treat some rare autoimmune diseases affecting small blood vessels.Tavneos was originally developed by ChemoCentryx, which was acquired by Amgen  in 2022, according to Amgen's website.The regulator said it reached its decision after reviewing all available evidence, advice from the Commission on Human Medicines, and feedback from patients and healthcare professionals.The supply will be allowed to existing patients during a six-month managed withdrawal period to allow safe alternative treatment options, the regulator said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0109394709.USD","IE0009355771.USD","TBXU","LU1571399168.USD","LU2089984988.USD","BK4599","LU2242652126.USD","PBE","IE00B4R5TH58.HKD","LU1061106388.HKD","LU0868494617.USD","LU2112291526.USD","LU0320765992.SGD","LU1983299246.USD","BBH","BK4581","BK4566","BIB","IE00BFTCPJ56.SGD","BK4588","LU0058720904.USD","BK4585","AMGN","LU0122379950.USD","LU0289739699.SGD","LU2242646821.SGD","IBBQ","BK4534","IE00B2B36J28.USD","LU0889565916.HKD","PJP","IE00BJJMRZ35.SGD","LU1057294990.SGD","BK4533","LU2468319806.SGD","IE0002141913.USD","BK4139","IBB","LU1023059063.AUD","IE00BJT1NW94.SGD","SG9999001440.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664985383","title":"Novartis halts autoimmune CAR-T trials following three deaths, Reuters says","url":"https://stock-news.laohu8.com/highlight/detail?id=2664985383","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664985383?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:30","pubTimestamp":1788258648,"startTime":"0","endTime":"0","summary":"Novartis (NVS) has paused eight clinical trials of rap-cel, an experimental cell therapy targeting autoimmune and neurological disorders, after thr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-halts-autoimmune-car-t-trials-following-three-deaths-reuters-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-halts-autoimmune-car-t-trials-following-three-deaths-reuters-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","IE0002141913.USD","IBB","IE00BJT1NW94.SGD","HYLG","TBXU","LU0208291251.USD","IE00BFTCPJ56.SGD","GNOM","IDNA","FBT","IE0009355771.USD","BK4578","BMED","SYNB","BK4007","BK4585","IE00B2B36J28.USD","LU0070302665.USD","LU0211331839.USD","BK4588","IE00B4R5TH58.HKD","NVIB","IE00BJJMRZ35.SGD","LU0320765489.SGD","NVS","GDOC","PPH","BK4532","CNCR","MEDX","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664287830","title":"Vertex Pharmaceuticals added to US Conviction List at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2664287830","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664287830?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:40","pubTimestamp":1788255621,"startTime":"0","endTime":"0","summary":"Goldman Sachs analysts added Vertex Pharmaceuticals (VRTX) to the firm’s US Conviction List as part of its monthly update. Goldman believes Vertex ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-added-to-us-conviction-list-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-added-to-us-conviction-list-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1093756325.SGD","LU1815336091.USD","LU2362540622.SGD","BK4127","LU1868836914.USD","LU2089984988.USD","IDNA","LU2237443895.HKD","LU2471134952.CNY","IE0004091025.USD","IE00BZ9MQY76.HKD","BK4504","LU0345770993.USD","LU2471134796.USD","LU1668664300.SGD","VRTX","LU0868494708.USD","IE00B894F039.SGD","IBB","LU1894683264.USD","LU2362541273.HKD","IE0002270589.USD","LU1585245621.USD","IE0034235188.USD","PBE","LU0417517546.SGD","GNMX","LU0432979614.USD","LU2237443382.USD","LU1035775433.USD","LU2471134879.HKD","LU0757428866.USD","LU1778281490.HKD","BIB","GSX","LU2362541513.USD","LU0106831901.USD","IE00BSNM7G36.USD","IE00B2B36J28.USD","IE00B19Z3581.USD","IBBQ","TBXU","IE00BJT1NW94.SGD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU2236285917.USD","SGXZ57979304.SGD","VERX","BBH","LU1430594728.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664837149","title":"UK's Mhra : Informed Marketing Authorisation Holder of Decision to Suspend Use, Supply, Sale of Avacopan Vifor for New Patients from 1 September","url":"https://stock-news.laohu8.com/highlight/detail?id=2664837149","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664837149?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:29","pubTimestamp":1788254980,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44S0UF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LU1571399168.USD","IE0009355771.USD","LU0320765992.SGD","IE00B2B36J28.USD","LU0109394709.USD","SG9999001440.SGD","BK4588","BK4534","BK4566","LU0868494617.USD","LU0058720904.USD","LU1983299246.USD","BK4533","IE0002141913.USD","LU2242652126.USD","BK4585","BBH","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0122379950.USD","LU1023059063.AUD","LU1057294990.SGD","TBXU","LU0289739699.SGD","BIB","LU0889565916.HKD","IE00BJJMRZ35.SGD","IBBQ","PJP","LU1061106388.HKD","LU2089984988.USD","LU2112291526.USD","BK4599","LU2242646821.SGD","AMGN","BK4581","LU2468319806.SGD","IBB","PBE","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883471","title":"Latigo Biotherapeutics initiated with a Buy at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883471","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883471?lang=en_us&edition=fundamental","pubTime":"2026-09-01 16:30","pubTimestamp":1788251407,"startTime":"0","endTime":"0","summary":"Goldman Sachs initiated coverage of Latigo Biotherapeutics (LTGO) with a Buy rating and $73 price target Latigo is clinical-stage biotechnology com...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/latigo-biotherapeutics-initiated-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/latigo-biotherapeutics-initiated-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4504","IE0002270589.USD","LU1868836757.USD","FWD","LU0210536198.USD","LU0868494617.USD","LU1668664300.SGD","LU1868837136.USD","LU1868836914.USD","LU2237443622.USD","IEIH","FHLC","LU0106831901.USD","JDOC","IE0004091025.USD","LNGR","LU1894683348.USD","SYNB","BK4585","BK4127","IBB","LU0942090050.USD","AGNG","LU1868836591.USD","LU2896262040.SGD","BK4552","BK4007","IE0004086264.USD","LU2237443895.HKD","LU2471134796.USD","LU0096364046.USD","LU2237443382.USD","LU2237443549.SGD","LU0345770993.USD","LU2471134523.USD","GSX","XT","IE00BSNM7G36.USD","BBC","LU1144417596.USD","IE00BFXG1179.USD","DARP","BK4516","IE00B19Z3B42.SGD","LU0251131958.USD","LU2237438978.USD","RSPH","LTGO","BBP","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664832384","title":"Why Is Amgen (AMGN) In Focus After New Repatha Survival Data?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664832384","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664832384?lang=en_us&edition=fundamental","pubTime":"2026-09-01 16:18","pubTimestamp":1788250703,"startTime":"0","endTime":"0","summary":"Amgen (NasdaqGS:AMGN) reported new Phase 3 VESALIUS-CV trial results for Repatha (evolocumab) showing a reduction in risk of death for high-risk adults without prior heart attack or stroke, presented at the European Society of Cardiology Congress 2026.\nThe findings extend evidence for Repatha to a broader high-risk population beyond patients with established cardiovascular events.\nAmgen highlighted that the data may inform future treatment guidelines and prescribing decisions in...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/24816-main-header/1756203123218","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/24816-main-header/1756203123218"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amgn/amgen/news/why-is-amgen-amgn-in-focus-after-new-repatha-survival-data","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amgn/amgen/news/why-is-amgen-amgn-in-focus-after-new-repatha-survival-data","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE0009355771.USD","IE00BFTCPJ56.SGD","BBH","LU0109394709.USD","PJP","BK4599","LU1023059063.AUD","BK4588","LU1061106388.HKD","LU2468319806.SGD","TBXU","LU2112291526.USD","BIB","IBBQ","BK4585","IE00BJT1NW94.SGD","IE0002141913.USD","BK4534","LU0889565916.HKD","IBB","LU1983299246.USD","LU2242652126.USD","LU0289739699.SGD","IE00B2B36J28.USD","LU0058720904.USD","LU1057294990.SGD","LU2242646821.SGD","BK4566","BK4533","LU0320765992.SGD","BK4139","LU0868494617.USD","LU1571399168.USD","SG9999001440.SGD","PBE","IE00B4R5TH58.HKD","AMGN","LU0122379950.USD","BK4581","LU2089984988.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664838571","title":"Vertex Advances Share Buyback, Acquires 445,500 Shares by August","url":"https://stock-news.laohu8.com/highlight/detail?id=2664838571","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664838571?lang=en_us&edition=fundamental","pubTime":"2026-09-01 12:22","pubTimestamp":1788236545,"startTime":"0","endTime":"0","summary":"Vertex Corp. ( ($JP:5290) ) has provided an announcement. Vertex Corporation reported the progress of its ongoing share buyback program, authorized...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-advances-share-buyback-acquires-445500-shares-by-august?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-advances-share-buyback-acquires-445500-shares-by-august?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1430594728.SGD","LU0109394709.USD","IE00BFTCPJ56.SGD","BBH","IE00B19Z9P08.USD","ACKY","IE00BZ9MQY76.HKD","BK4588","BRKL","LU2468319806.SGD","LU0234570918.USD","BRKU","LU2456880835.USD","TBXU","LU2362541513.USD","LU1559883803.SGD","VERX","LU1069344957.HKD","BRKD","SG9999001176.USD","BIB","IBBQ","LU0256863811.USD","IE00BJT1NW94.SGD","BRKW","IE0002141913.USD","LU0889565916.HKD","LU0757428866.USD","IBB","LU1815336091.USD","LU0061475181.USD","LU2237438978.USD","ACTV","IE00B2B36J28.USD","BK4567","LU0058720904.USD","LU1585245621.USD","LU2462157665.USD","LU0417517546.SGD","LU0320765992.SGD","LU1035775433.USD","BK4139","IDNA","PBE","LU1674673428.USD","GNMX","LU1778281490.HKD","BRKC","VRTX","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664838493","title":"Vertex (VRTX) Stock Looks Reasonable As Growth Must Justify Its Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2664838493","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664838493?lang=en_us&edition=fundamental","pubTime":"2026-09-01 10:20","pubTimestamp":1788229256,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals has delivered strong long term gains over the past five years, yet current valuation checks suggest the stock now looks closer to fairly priced than clearly cheap. For investors, the question is how that past share price performance lines up with what the broader valuation signals are saying today.\n\nThe stock has returned 174.9% over five years, which puts extra focus on whether recent strength already reflects much of the good news in the story.\nFuture growth in cash...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/36235-main-header/1756253398031","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/36235-main-header/1756253398031"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrtx/vertex-pharmaceuticals/news/vertex-vrtx-stock-looks-reasonable-as-growth-must-justify-it","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrtx/vertex-pharmaceuticals/news/vertex-vrtx-stock-looks-reasonable-as-growth-must-justify-it","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0823416689.USD","IBBQ","LU1035775433.USD","IBB","LU2089984988.USD","SG9999001176.USD","LU0432979614.USD","LU2324357040.USD","CDIG","LU0566484027.USD","BIB","IE00B19Z3581.USD","IE0002141913.USD","LU1069344957.HKD","LU1674673428.USD","IE0009355771.USD","LU1674673691.USD","LU0079474960.USD","IE00BJJMRZ35.SGD","LU1559883803.SGD","VERX","LU0109394709.USD","PBE","BK4588","LU0061475181.USD","LU2362540622.SGD","LU1430594728.SGD","IE00BZ9MQY76.HKD","LU0889565916.HKD","BK4532","TBXU","SG9999001176.SGD","IE00B19Z3B42.SGD","IE00B19Z9Z06.USD","VRTX","TACU","LU1815336091.USD","GNMX","LU1778281490.HKD","TSPA","LU0289739699.SGD","IDNA","SGXZ57979304.SGD","BK4585","LU1093756168.USD","BBH","LU2417539215.USD","IE00B2B36J28.USD","BK4139","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664881767","title":"Actinogen Plans Major Share Placement to Bolster Funding Capacity","url":"https://stock-news.laohu8.com/highlight/detail?id=2664881767","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664881767?lang=en_us&edition=fundamental","pubTime":"2026-09-01 08:46","pubTimestamp":1788223606,"startTime":"0","endTime":"0","summary":"Actinogen Medical ( ($AU:ACW) ) just unveiled an update. Actinogen Medical Limited, an ASX-listed biotechnology company trading under the code ACW,...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actinogen-plans-major-share-placement-to-bolster-funding-capacity?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actinogen-plans-major-share-placement-to-bolster-funding-capacity?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","IBB","JDOC","XT","AGNG","FWD","RSPH","DARP","IEIH","BBP","SYNB","BK4585","FHLC","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664854881","title":"Is Pasatru’s Rare Disease Approval With Home Infusion Potential Altering The Investment Case For Regeneron Pharmaceuticals (REGN)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664854881","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664854881?lang=en_us&edition=fundamental","pubTime":"2026-09-01 07:17","pubTimestamp":1788218267,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals has secured past FDA approval for Pasatru (garetosmab-grts), a VelocImmune-derived monoclonal antibody that reduces new heterotopic ossification lesions and clinician-assessed flare-ups in adults with fibrodysplasia ossificans progressiva, based on Phase 3 OPTIMA trial data.\nThis approval introduces a new rare disease therapy that can be infused monthly, including in home settings, and is supported by strong lesion-reduction outcomes against placebo while carrying...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/is-pasatrus-rare-disease-approval-with-home-infusion-potenti","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/is-pasatrus-rare-disease-approval-with-home-infusion-potenti","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ARTY","BK4211","LU1917777945.USD","VTHR","BK4195","LU0823434740.USD","LU2362541513.USD","LU0823416689.USD","TBXU","LU0289739699.SGD","LU2362540622.SGD","AIPO","LU2023250504.SGD","LU2237438978.USD","IBB","LU0053666078.USD","LU2106854487.HKD","LU0058720904.USD","HBCP","LU0823434583.USD","IBBQ","QTOC","LU1974910355.USD","BK4588","LU2362541273.HKD","LU2468319806.SGD","LU0882574055.USD","LU0109394709.USD","LU0889565916.HKD","LU0320765992.SGD","LU0114720955.EUR","CHAT","BBH","BK4139","REGN","AGIX","LU2089984988.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664925888","title":"Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2664925888","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664925888?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:53","pubTimestamp":1788205998,"startTime":"0","endTime":"0","summary":"UPDATE 2-Trump administration announces drug pricing deals with CSL, Astellas and othersWASHINGTON, Aug 31 (Reuters)-U.S. President Donald Trump announced a new round of drug-pricing agreements with i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S0RA:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300485","BK4566","BK7511","LU2112291526.USD","LU2468319806.SGD","PJP","LU1057294990.SGD","LU1983299246.USD","BBH","BK4534","AMGN","IE00BBT3K403.USD","LU1883839398.USD","LU0320765992.SGD","688235","IE00BJT1NW94.SGD","BK0028","IE00BFTCPJ56.SGD","LU0109394709.USD","LU0889565916.HKD","BK0012","BK0046","SG9999001176.SGD","IE00BLSP4239.USD","IONS","LU2242646821.SGD","CSL.AU","BK4007","PBE","IE00BJJMRZ35.SGD","BK4505","LU0321505439.SGD","OZEM","BK4550","IE0002141913.USD","LU0306806265.USD","TBXU","IE00B3T34201.USD","BBIO","LU1894683348.USD","IE00BLSP4452.SGD","PFE","IBB","LU0225284248.USD","IE0002270589.USD","SGXZ57979304.SGD","LU0868494617.USD","SG9999002224.SGD","BIB","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664000711","title":"Circio boosts circVec gene therapy data and secures funding runway to 2030","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000711","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664000711?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:03","pubTimestamp":1788203022,"startTime":"0","endTime":"0","summary":"The latest update is out from Targovax ASA ( ($GB:0RIS) ). Circio Holding ASA reported that new preclinical data show its circVec circular RNA tech...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/circio-boosts-circvec-gene-therapy-data-and-secures-funding-runway-to-2030?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/circio-boosts-circvec-gene-therapy-data-and-secures-funding-runway-to-2030?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNA","BK4588","BK4585","FBT","GNOM","CNCR","TBXU","IBB","BK4505","IE0009354923.USD","IBBQ","LFSC","BK4139","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664007498","title":"iShares Biotechnology ETF Announces Q3 2026 Dividend of R$ 0.02 Per Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2664007498","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664007498?lang=en_us&edition=fundamental","pubTime":"2026-09-01 01:46","pubTimestamp":1788198368,"startTime":"0","endTime":"0","summary":"iShares Biotechnology ETF announces Q3 2026 dividend of R$ 0.02 per unitiShares Biotechnology ETF declared a 3Q 2026 cash distribution of BRL 0.02 per unit.Units trade with entitlement through Sept. 14.Payment is scheduled for Sept. 24.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. iShares Biotechnology ETF published the original content used to generate this news brief on August 31, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL9CMGGK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664007127","title":"Sector Update: Healthcare Stocks Decline Monday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2664007127","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664007127?lang=en_us&edition=fundamental","pubTime":"2026-09-01 01:37","pubTimestamp":1788197856,"startTime":"0","endTime":"0","summary":"Healthcare stocks were lower Monday afternoon, with the NYSE Healthcare Index decreasing 0.5% and the State Street Health Care Select Sector SPDR ETF (XLV) down 0.4%.The iShares Biotechnology ETF (IBB","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LLII","LU1232071149.USD","LU0471298777.SGD","LU0823434583.USD","IE00BKDWB100.SGD","LU1145028129.USD","IE0004445239.USD","LU1629891620.HKD","LU0456855351.SGD","LU0820562030.AUD","LU2746668974.SGD","LU0316494557.USD","GB00BDT5M118.USD","SGXZ81514606.USD","BK4599","CANC","LU1551013342.USD","LU2750360997.AUD","LU0417517546.SGD","LU0353189680.USD","WDNA","LU0345770993.USD","LU2089283258.USD","LU0266013472.USD","LU0466842654.USD","LU0882574139.USD","SG9999014880.SGD","IYH","LU0786609619.USD","LU1551013425.SGD","LU2237438978.USD","LU2602419157.SGD","LU0320765059.SGD","SG9999013999.USD","ELIL","LU2462157665.USD","LU2756315664.SGD","OZEM","LU1804176565.USD","LU1868836757.USD","LU0820561818.USD","IE00BN29S564.USD","LU1061106388.HKD","LU2361044949.HKD","LU1127390331.HKD","LU1712237335.SGD","LU0320765992.SGD","LU1974910355.USD","IE00BJJMRX11.SGD","LU1267930730.SGD","LU2236285917.USD","RXL","LLYX","LU0106261372.USD","ELIS","FTXH","XLV","LU2746668461.USD","SG9999015978.USD","LU1814569148.SGD","IE00B2B36J28.USD","SG9999017495.SGD","IE0009355771.USD","LU1280957306.USD","LU2552382215.SGD","IE00BFSS8Q28.SGD","LU0174119429.USD","LU2461242641.AUD","LU2471134796.USD","SGXZ57979304.SGD","TRUH","LU2168563687.JPY","LU1023059063.AUD","LU0354030511.USD","LU1720051108.HKD","LU2211815571.USD","LU2360106947.USD","LU0943347566.SGD","LU0133085943.USD","LU2361044865.SGD","IBB","LU0061475181.USD","LU1093756168.USD","LU2471134523.USD","LU2456880835.USD","LU0672654240.SGD","LU0354030438.USD","LU2491050071.SGD","LU0097036916.USD","IHE","LLYZ","LU0109391861.USD","BK4585","IE00BK4W5L77.USD","LU0109394709.USD","IE00BKPKM429.USD","LU2087625088.SGD","LU2417539215.USD","LU0820561909.HKD","MEDI","BK4534","LU2324357040.USD","FHLC","LU0964807845.USD","LLY","SGXZ31699556.SGD","IE00BJJMRZ35.SGD","LU0122379950.USD","BK4007","LU0158827948.USD","LU0432979614.USD","SG9999001176.USD","LU2237443622.USD","LU0058720904.USD","MEDX","LU1291159041.SGD","IE00B1BXHZ80.USD","LU0203202063.USD","LU2089284900.SGD","LU2264538146.SGD","SG9999018857.SGD","LU2462591350.SGD","LU2028103732.USD","LU0689472784.USD","AGNG","LU0225283273.USD","PPH","LU1548497426.USD","IE00BK4W5M84.HKD","SG9999015986.USD","LU0323591593.USD","LU1064131342.USD","IE00B1XK9C88.USD","LU1983299246.USD","LU1989771016.USD","SG9999014898.SGD","LU2271345857.HKD","LU0683600562.USD","LU0353189763.USD","IE00BFSS7M15.SGD","LU1988902786.USD","IE0005OL40V9.USD","LU0882574055.USD","LU2108987350.USD","LU2750360641.GBP","LU1069344957.HKD","SG9999014914.USD","BK4533","LU0345770308.USD","LU0889565916.HKD","LU1366192091.USD","LU2552382132.HKD","LU2265009873.SGD","LU0256863811.USD","IE00BJT1NW94.SGD","GDOC","LU2023251221.USD","LABU","LU2023250330.USD","LU2237443978.SGD","LU1868836591.USD","LU2237443895.HKD","SG9999018865.SGD","LU1057294990.SGD","LU2491050154.USD","LU0203201768.USD","LU0096364046.USD","LU2468319806.SGD","SG9999015952.SGD","ALVO","LU1323610961.USD","SG9999014906.USD","LU0114720955.EUR","IE0001KFT4U8.USD","IE00B7KXQ091.USD","LU0708995401.HKD","LU2237443549.SGD","LU2896262040.SGD","VHT","LU0234572021.USD","LU0158827781.USD","LU0006306889.USD","TMED","JDOC","LU2168564222.USD","LU0640476718.USD","LU1868837300.USD","PJP","LU0471298694.HKD","LU2168564495.EUR","LU2237443382.USD","LU2168564065.EUR","HRTS","LU1691799644.USD","SGXZ99366536.SGD","LU2357305700.SGD","SGXZ51526630.SGD","IE00BWXC8680.SGD","LU2552382058.USD","BK4139","IXJ","LU1093756325.SGD","LU2168564149.EUR","LU2237443465.HKD","IE00B4JS1V06.HKD","IE00BJLML261.HKD","LU1720051017.SGD","THNR","LU0079474960.USD","SG9999015945.SGD","LU2491049909.HKD","LU0823416689.USD","SG9999001176.SGD","LU0094547139.USD","LU0198837287.USD","LU2063271972.USD","IE00B4R5TH58.HKD","LU2471134952.CNY","LU2213496289.HKD","LU2089984988.USD","IE0002141913.USD","LU0385154629.USD","LU2023250504.SGD","IE00BJJMRY28.SGD","IE00BFTCPJ56.SGD","LU2756315318.SGD","LU1868836914.USD","IE00B775H168.HKD","LU0256863902.USD","BK4588","LU2106854487.HKD","IE0004445015.USD","LU2112291526.USD","XBI","LU1623119135.USD","LU2111349929.HKD","LU0289739699.SGD","BK4581","LU1917777945.USD","BK4516","CURE","LU0787776722.HKD","LU1035775433.USD","LU2471134879.HKD","LU1868837136.USD","LU2361045086.USD","ILDR","LU0210536198.USD","LU0238689110.USD","LU0823434740.USD","LU1979441026.SGD","MHIP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663561006","title":"Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as US, Iran Exchange Attacks","url":"https://stock-news.laohu8.com/highlight/detail?id=2663561006","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663561006?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:28","pubTimestamp":1788182880,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.3%, and the actively traded Invesco QQQ Trust (QQQ) retreated 0.2% in Monday's premarket activity as the US and Iran excha","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IYW","QQQ","FAS","EETH","IGM","IYK","USO","VIS","AON","EXI","GLD","GME","RTH.AU","SOXX","XLV","XLY","FAZ","KKR","SPY","SAIC","UNG","XSD","VDC","XLF","FDN","PCG","XLK","IYE","SPY.AU","SPCX","VHT.AU","DRTS","EQR","XRT","VHT","PCG.AU","IVV","PMR","RTH","XLE","IYJ","BITO","AON.AU","IYH","SLV","XLP","IBB","BETH","XLI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663005748","title":"Political and General News Events from August 31","url":"https://stock-news.laohu8.com/highlight/detail?id=2663005748","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663005748?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:15","pubTimestamp":1788182117,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from August 31Aug 31 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/DI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4N44S10Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","LU2112291526.USD","BBH","PJP","IE00B2B36J28.USD","BK4585","BIB","IE0009355771.USD","LU1057294990.SGD","LU1983299246.USD","BK4534","LU0058720904.USD","IE00BJJMRZ35.SGD","LU2242646821.SGD","BK4588","PBE","LU1023059063.AUD","BK4566","BK4581","BK4533","IE00B4R5TH58.HKD","LU0109394709.USD","LU0122379950.USD","SG9999001440.SGD","IE00BFTCPJ56.SGD","TBXU","BK4139","IE00BJT1NW94.SGD","IBBQ","IBB","LU0889565916.HKD","IE0002141913.USD","LU1061106388.HKD","LU0289739699.SGD","LU1571399168.USD","LU2468319806.SGD","LU0868494617.USD","LU0320765992.SGD","BK4599","LU2242652126.USD","AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663200514","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2663200514","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663200514?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:04","pubTimestamp":1788181452,"startTime":"0","endTime":"0","summary":"Healthcare stocks were falling premarket Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) 0.5% lower and the iShares Biotechnology ETF (IBB) down 0.6%.Arrowhead Pharmaceuticals' ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0128526141.USD","LABU","BK4137","BK4585","BK4139","HCSG","XBI","IBB","LU0029874061.USD","XLV","BK4581","ARWR","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663071381","title":"Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2663071381","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663071381?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:51","pubTimestamp":1788169915,"startTime":"0","endTime":"0","summary":"Amgen  said Monday that its cholesterol-lowering drug Repatha reduced the risk of death by 20% in high-risk adults without a prior heart attack or stroke.The findings came from a pre-specified analysis of the phase 3 VESALIUS-CV trial involving more than 12,000 patients and were presented at the European Society of Cardiology Congress 2026 in Munich, it said.Amgen said Repatha reduced both overall and cardiovascular deaths when added to statins or other LDL-C-lowering treatments. The mortality benefit emerged after about 1.5 years and continued through a median follow-up of 4.6 years, it added.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BBH","BK4585","BK4599","LU1057294990.SGD","IBBQ","LU1571399168.USD","AMGN","IE00B2B36J28.USD","PJP","BK4534","IE00BJJMRZ35.SGD","PBE","LU2112291526.USD","BK4581","LU0289739699.SGD","TBXU","LU2089984988.USD","LU2468319806.SGD","BK4139","LU2242652126.USD","IBB","LU0122379950.USD","IE0009355771.USD","LU0868494617.USD","LU1061106388.HKD","SG9999001440.SGD","LU0889565916.HKD","BIB","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU2242646821.SGD","BK4588","LU0058720904.USD","LU1983299246.USD","BK4533","LU1023059063.AUD","IE0002141913.USD","IE00BJT1NW94.SGD","LU0109394709.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663249076","title":"Amgen Repatha reduces risk of death in high-risk adults for first heart attack","url":"https://stock-news.laohu8.com/highlight/detail?id=2663249076","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663249076?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:10","pubTimestamp":1788167413,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) announced new findings showing Repatha reduced the risk of death in high-risk adults without a prior heart attack or stroke when added...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-repatha-reduces-risk-of-death-in-high-risk-adults-for-first-heart-attack-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-repatha-reduces-risk-of-death-in-high-risk-adults-for-first-heart-attack-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BJT1NW94.SGD","LU1061106388.HKD","IE00BFTCPJ56.SGD","IE0002141913.USD","BK4588","LU2112291526.USD","BK4534","TBXU","SG9999001440.SGD","LU1983299246.USD","LU2242646821.SGD","BBH","LU0109394709.USD","BK4139","LU0868494617.USD","IE00B4R5TH58.HKD","BK4599","BK4585","IE0009355771.USD","BK4566","IE00B2B36J28.USD","LU1057294990.SGD","LU0289739699.SGD","PBE","LU1571399168.USD","LU0320765992.SGD","LU1023059063.AUD","IBBQ","LU2468319806.SGD","LU2242652126.USD","LU0122379950.USD","BK4533","LU0058720904.USD","LU2089984988.USD","LU0889565916.HKD","AMGN","IBB","IE00BJJMRZ35.SGD","BK4581","PJP","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663753250","title":"Chimeric Therapeutics posts deeper loss as IP impairments push it into net liabilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2663753250","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663753250?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:33","pubTimestamp":1788165205,"startTime":"0","endTime":"0","summary":"Chimeric Therapeutics Ltd. ( ($AU:CHM) ) has shared an announcement. Chimeric Therapeutics Limited is a biotechnology company focused on cell-based...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/chimeric-therapeutics-posts-deeper-loss-as-ip-impairments-push-it-into-net-liabilities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/chimeric-therapeutics-posts-deeper-loss-as-ip-impairments-push-it-into-net-liabilities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DARP","LNGR","SYNB","BK4585","AGNG","BK4588","XT","FWD","BBP","BK4007","RSPH","IEIH","BK4539","IBB","JDOC","LENZ","BK4139","FHLC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}